High-Dose Citalopram and Escitalopram: Undeserved Bad Rap?
The Carlat Psychiatry Report, Volume 15, Number 4, April 2017
Colleen Ryan, MD
Dr. Ryan has disclosed that she has no relevant financial or other interests in any commercial companies pertaining to this educational activity.
Selective serotonin reuptake inhibitors (SSRIs) are considered the first-line treatment for depression; however, our confidence in their safety took a hit when the FDA issued a warning in 2011 about doses of citalopram above 40 mg causing QTc prolongation.